7,8-Difluoroquinoline

Catalog No.: 
ACERPA870
CAS No.: 
145241-76-5
Molecular Formula: 
C9H5F2N
Molecular Weight: 
165.14
7,8-Difluoroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$116.00In stockIn stock
10g98%$168.00In stockInquiry
25g98%$407.00In stockIn stock
100g98%$1288.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7,8-Difluoroquinoline
IUPAC Name7,8-difluoroquinoline
MDL No.MFCD01075229
Molecular FormulaC9H5F2N
Molecular Weight165.14
SMILESFC1=C2N=CC=CC2=CC=C1F
InChI KeyMTJUOHUSWWHAHJ-UHFFFAOYSA-N
SynonymMFCD01075229 | AMS_CNC_ID-1808777807 | 7,8-Difluoroquinoline | MB01680 | Z1198156164 | A928639 | AS-43883 | EN300-124429 | AKOS006275561 | CS-0112254 | Quinoline, 7,8-difluoro- | SCHEMBL3562790 | CCRIS 8762 | DTXSID80162953 | SMSSF-0625306 | MTJUOHUSWWHAH
CAS No.145241-76-5
PubChem CID3025799

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACERPA870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLDIY152 route compound structure diagram
    ACLDIY1524519-40-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACERPA870 route product structure diagram
    ACERPA870145241-76-5In Stock
Inquiry

2. ACERPA870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACERPA870 route product structure diagram
    ACERPA870145241-76-5In Stock
Inquiry

3. ACERPA870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACERPA870 route product structure diagram
    ACERPA870145241-76-5In Stock
Inquiry

Comments (0)